904 Metformin Hydrochloride 500mg (Prolonged release) and Glimepiride 1mg Tablets IP

Metformin Hydrochloride 500mg (Prolonged Release) and Glimepiride 1mg Tablets IP offer a potent combination therapy for type 2 diabetes. The prolonged release of Metformin provides extended glucose control, while Glimepiride further aids in reducing blood sugar. Convenient and effective, these tablets are suited for patients needing tailored diabetes management.